Hangeshashinto for the prevention of oral mucositis in patients receiving with allogeneic hematopoietic stem cell transplantatio
Not Applicable
- Conditions
- Hematological malignancy
- Registration Number
- JPRN-UMIN000012275
- Lead Sponsor
- orth Japan Hematology Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients seropositive for HIV or HBs. 2) Severe psychiatric illness or any disorder that compromises ability to give truly informed consent for participation in this study. 3) Pregnant or breastfeeding women. 4) Patient has another progressive malignant disease. 5) Uncontrolled infections. 6) Acute Myocardial Infarction and heart failure within the last 12 months. 7) Liver cirrhosis. 8) BMI>=35. 9) Arrhythmias: CTCAE v4.0 Grade>=3. 10) Contraindication of Hangeshashinto. 11) Oral mucositis: CTCAE v3.0 Grade>=3. 12) Patients who, in the judgment of the investigator, would be inappropriate for entry into this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method